Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Kim Van der Eecken

Awards & Distinctions

31 Results

2025

Genomic determinants associated with modes of progression and patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer

Philip SuteraYang SongAmol C. ShettyKeara EnglishKim Van der EeckenOzan Cem GulerJarey WangYufeng CaoSoha BazyarSofie Verbeke et al.

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

2024

Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping

Evan W. WarnerKim Van der EeckenAndrew J. MurthaEdmond M. KwanCameron HerbertsJoonatan SipolaSarah W. S. NgXinyi E. ChenNicolette M. FonsecaElie Ritch et al.

A1 Journal Article in NATURE CANCER

TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment

Tung HoangPhilip SuteraTriet NguyenJinhee ChangShreya JagtapYang SongAmol C. ShettyDipanwita D. ChowdhuryAaron ChanFrancesca A. Carrieri et al.

A1 Journal Article in PROSTATE

2023

Clinical and genomic differences between advanced molecular imaging-detected and conventional imaging-detected metachronous oligometastatic castration-sensitive prostate cancer

Philip SuteraYang SongKim Van der EeckenAmol C ShettyKeara EnglishTheresa HodgesJinhee ChangValerie FonteyneZaker RanaLei Ren et al.

A1 Journal Article in EUROPEAN UROLOGY

Genomic determinants of patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer

Philip SuteraKim Van der EeckenAmol ShettyYang SongTheresa HodgesSofie VerbekeJo Van DorpeValerie FonteyneBram De LaereMark V. Mishra et al.

Overcoming complex polyclonality for accurate clinical genotyping in metastatic prostate cancer

Alexander W. WyattAndrew J. MurthaEvan WarnerKim Van der EeckenEdmond M. KwanCameron HerbertsJoonatan SipolaSarah W. S. NgXinyi E. ChenNicolette M. Fonseca et al.

WNT pathway mutations in metachronous oligometastatic castration-sensitive prostate cancer

Philip SuteraMatthew P. DeekKim Van der EeckenAmol C. ShettyJin Hee ChangTheresa HodgesYang SongSofie VerbekeJo Van DorpeValerie Fonteyne et al.

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

WSI based prediction of TP53 mutations identifies aggressive disease phenotype in prostate cancer

Marija PizuricaMaarten LarmuseauKim Van der EeckenLouise de Schaetzen van BrienenFrancisco Carrillo-PerezSimon IsphordingNicolaas LumenJo Van DorpePiet OstSofie Verbeke et al.

Whole slide imaging-based prediction of TP53 mutations identifies an aggressive disease phenotype in prostate cancer

Marija PizuricaMaarten LarmuseauKim Van der EeckenLouise de Schaetzen van BrienenFrancisco Carrillo-PerezSimon IsphordingNicolaas LumenJo Van DorpePiet OstSofie Verbeke et al.

A1 Journal Article in CANCER RESEARCH

2022

Genomic biomarkers to guide precision radiotherapy in prostate cancer

Philip SuteraMatthew P. DeekKim Van der EeckenAlexander W. WyattAmar U. KishanJason K. MolitorisMatthew J. FerrisM. Minhaj SiddiquiZaker RanaMark V. Mishra et al.

A1 Journal Article in PROSTATE

Genomic features of lung-recurrent hormone-senstive prostate cancer

Nicolette M. FonsecaKim Van der EeckenCameron HerbertsSofie VerbekeSarah W. S. NgNicolaas LumenElie RitchAndrew J. MurthaCecily Q. BernalesElena Schonlau et al.

A1 Journal Article in JCO PRECISION ONCOLOGY

Multi-focal genomic dissection of synchronous primary and metastatic tissue from de novo metastatic prostate cancer

A. J. MurthaE. WarnerKim Van der EeckenE. KwanC. HerbertsJ. SipolaS. NgE. ChenN. FonsecaE. Schonlau et al.

Shallow whole-genome sequencing : a useful, easy to apply molecular technique for CNA detection on FFPE tumor tissue : a glioma-driven study

Kim Van der EeckenMalaïka Van der LindenLennart RamanDavid CreytensFranceska DedeurwaerdereKoen De WinneLiesbeth FerdinandeMartin LammensBjörn MentenIsabelle Rottiers et al.

A1 Journal Article in VIRCHOWS ARCHIV

Towards the discovery of prognostic and predictive biomarkers in CHEERS, a radioimmunotherapy phase II trial

Jan VanwelkenhuyzenMathieu SpaasKim Van der EeckenVibeke KruseSylvie RotteyLieve BrochezJohan LindbergKatleen De PreterBram De LaerePiet Ost

Unraveling the genomic underpinnings of advanced prostate cancer

Kim Van der EeckenPiet OstJo Van DorpeSofie Verbeke

2021

Clinical and genomic indolence in lung-recurrent metastatic hormone-sensitive prostate cancer

Nicolette FonsecaKim Van der EeckenCameron HerbertsSofie VerbekeSarah NgNicolaas LumenElie RitchAndrew MurthaCecily BernalesElena Schönlau et al.

Combined longitudinal clinical and autopsy phenomic assessment in lethal metastatic prostate cancer : recommendations for advancing precision medicine

Juho JasuTeemu TolonenEmmanuel S. AntonarakisHimisha BeltranSusan HalabiMario A. EisenbergerMichael A. CarducciYohann LoriotKim Van der EeckenMartijn Lolkema et al.

A1 Journal Article in EUROPEAN UROLOGY OPEN SCIENCE

Emerging prognostic groups across the spectrum of metastatic castration-sensitive prostate cancer : disease outcomes and genomics

P. SuteraKim Van der EeckenA.U. KishanA. HamidE. GristG. AttardT.L. LotanA. MendesC. SweeneyC. Paller et al.

Genomic features of lung-recurrent hormone sensitive prostate cancer

Kim Van der EeckenNicolette FonsecaCameron HerbertsSofie VerbekeSarah NgNicolaas LumenElie RitchAndrew MurthaCecily BernalesElena Schönlau et al.

Multifocality in prostate cancer : implications for PAM50 subtyping using an index lesion-only approach

Kim Van der EeckenMaarten LarmuseauJan VanwelkenhuyzenNicolaas LumenKathleen MarchalJo Van DorpePiet OstBram De LaereSofie Verbeke

The mutational landscape of metastatic castration-sensitive prostate cancer : the spectrum theory revisited

Matthew P. DeekKim Van der EeckenRyan PhillipsNeil R. ParikhPedro Isaacsson VelhoTamara L. LotanAmar U. KishanTobias MaurerPaul C. BoutrosChristopher Hovens et al.

A1 Journal Article in EUROPEAN UROLOGY

Tissue- and blood-derived genomic biomarkers for metastatic hormone-sensitive prostate cancer : a systematic review

Kim Van der EeckenJan VanwelkenhuyzenMatthew P. DeekPhuoc T. TranEvan WarnerAlexander W. WyattEdmond M. KwanSofie VerbekeJo Van DorpeValerie Fonteyne et al.

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

2020

Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples

Louise de Schaetzen van BrienenMaarten LarmuseauKim Van der EeckenFrederic De RyckPauline Robbe VandewalleAnna SchuhJan FostierPiet OstKathleen Marchal

A1 Journal Article in BMC MEDICAL GENOMICS

Inferring the genomic landscape of lymph-node positive high-risk prostate cancer

Jan VanwelkenhuyzenKim Van der EeckenBram De LaereSimon SundlingRebecka BergströmJohan LindbergKatleen De PreterHenrik GrönbergPiet Ost

Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma

Lennart RamanMalaïka Van der LindenKim Van der EeckenKarim VermaelenIngel DemedtsVeerle SurmontUlrike HimpeFranceska DedeurwaerdereLiesbeth FerdinandeYolande Lievens et al.

A1 Journal Article in GENOME MEDICINE

Tracking the origins of metastatic seeding in de novo metastatic prostate cancer

Kim Van der EeckenEvan WarnerNicolaas LumenMatti AnnalaAndrew MurthaElena SchönlauNicolette FonsecaCameron HerbertsJan VanwelkenhuyzenWesley Verla et al.

2019

Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer : not ready for prime time

Bert DhondtElise De BleserTom ClaeysSarah BuelensNicolaas LumenJo VandesompeleAnneleen BeckersValerie FonteyneKim Van der EeckenAurélie De Bruycker et al.

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Oligometastatic prostate cancer : the game is afoot

Andrea LanciaThomas ZilliVerane AchardPiet DirixWouter EveraertsAlfonso Gomez-IturriagaGianluca IngrossoNick LiefhoogheRaymond MiralbellShankar Siva et al.

A1 Journal Article in CANCER TREATMENT REVIEWS

Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results

Piet OstNora SundahlG VandekerkhoveKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls Goetghebeur et al.

Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma

Nora SundahlGillian VandekerkhoveKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls GoetghebeurJo Van Dorpe et al.

A1 Journal Article in EUROPEAN UROLOGY

Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results

Gillian VandekerkhoveNora SundahlKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls GoetghebeurJo Van Dorpe et al.